Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Eculizumab's trials
ECU-NMO-304
Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD
Eculizumab
Ongoing
Active not recruiting
Phase 3
Open NCT06724809 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
